People with non-small cell lung cancer that have the ALK genetic mutation have a new option for treatment called XALKORI (crizotinib). It is a very effective oral drug with the potential to give an average of 8 months of remission. This is exciting news for this type of cancer. Ask your oncologist if your tumor has been tested for the ALK mutation.
No comments:
Post a Comment